About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Staccato Loxapine Pulmonary Safety in Patients With Asthma

NCT00890175·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Alexza Pharmaceuticals, Inc.

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

History of mild to moderate persistent asthma for at least 6 months with pre-bronchodilator FEV1 ≥60% of predicted value.

You may not be if

History of COPD, or any other acute or chronic pulmonary disease

The record

StatusCompleted

PhasePhase 1

Taking part52

StartedMay 2009

UpdatedMar 15, 2017

Conditions

Where1

Allergy and Asthma Medical Group & Research Center, A.P.C.
San Diego, California, United States

Clareo Health | Staccato Loxapine Pulmonary Safety in Patients With Asthma